Our Firm has been involved in the nationwide transvaginal mesh litigation since the beginning stages of this litigation. Since then, we have worked tirelessly to help our clients realize the justice they deserve.
New York, NY (PRWEB) March 01, 2015
The number of transvaginal mesh lawsuits (http://www.vaginalmeshlawsuit2015.com/) has grown substantially over the past few weeks in two New Jersey litigations where attorneys at Bernstein Liebhard LLP are actively filing claims, the Firm announces.
A Case List updated on February 21, 2015 reflects 7,713 cases in the Bergen County proceeding established for products manufactured by Johnson & Johnson's subsidiary, Ethicon Inc., compared with a few weeks earlier, when 90 fewer cases had been centralized. Additionally, 1,700 cases are now included in a docket that includes lawsuits over C.R. Bard products. These cases similarly allege chronic pain, pain during sexual intercourse, infection and other complications that occur after the mesh erodes, and often necessitate revision surgery to remove the implant. Transvaginal mesh lawsuits filed by Bernstein Liebhard LLP and other law firms involved in the litigation accuse Ethicon and C.R. Bard of failing to adequately warn about these and other side effects that allegedly result from their products. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
“Our Firm has been involved in the nationwide transvaginal mesh litigation since the beginning stages of this litigation. Since then, we have worked tirelessly to help our clients realize the justice they deserve,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is offering free and confidential case evaluations to women who were allegedly harmed by a transvaginal mesh device manufactured by C.R. Bard, Johnson & Johnson’s Ethicon unit, American Medical Systems or Boston Scientific Corp.
Transvaginal Mesh Lawsuits
Transvaginal mesh lawsuit victims represented by Bernstein Liebhard LLP filed their cases after a U.S. Food and Drug Administration (FDA) alert in 2008, which was the agency’s first to address the risk for complications.* At the time, the potential for women to experience issues following implantation of the devices, which are designed to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI) was described by the agency as “rare,” a category that was bumped up three years later to “not rare.” This revised stance was included in a second alert issued in 2011 that noted a five-fold increase in the number of adverse event reports from women who received transvaginal mesh since 2008.
As the nationwide mesh litigation continued to progress, Bernstein Liebhard LLP has remained on the forefront—with firm partner, Jeffrey S. Grand, serving as Co-Liaison Counsel in the New Jersey litigations. Mr. Grand was also a member of the Plaintiff’s trial team in a case filed in the Ethicon proceeding that concluded in March 2013 with an $11 million compensatory damage award to the Plaintiff, whose injuries were caused by the company’s Gynecare Prolift device.
Mr. Grand is also serving on the Plaintiff’s Steering Committee in all seven of the federal multidistrict litigations underway in the U.S. District Court, Southern District of West Virginia. These proceedings include: In Re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation - MDL No. 2326; In re: Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation - MDL No. 2327; In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2325; In Re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation - MDL No. 2187; Coloplast Corp. Pelvic Support Systems Products Liability Litigation - MDL No. 2387; In Re: Cook Medical, Inc., Pelvic Repair System Products Liability Litigation - MDL No. 2440; and In Re: Neomedic Pelvic Repair System Products Liability Litigation - MDL No. 2511.
Women who were allegedly harmed by transvaginal mesh may be eligible to receive compensation for medical bills, lost wages, pain and suffering and other damages. Find out more about transvaginal mesh complications by visiting Bernstein Liebhard LLP's website or the firm's Facebook page: https://www.facebook.com/meshlawsuit. To arrange for a free legal consultation, please call 800-511-5092.
*fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm061976.htm, FDA, October 2008
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP